EWING, N.J., Nov. 29, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) today announced the availability of XYOSTED™ (testosterone enanthate) injection. XYOSTED™ is the only FDA approved ...
If you have low testosterone levels, your doctor may recommend testosterone replacement therapy with Xyosted. Xyosted is a prescription drug used in adult males* to treat testosterone deficiency (low ...
Xyosted (testosterone enanthate) is a prescription drug used to treat low testosterone levels in certain people. The drug comes as a liquid solution inside prefilled autoinjector pens. It’s usually ...
The US Food and Drug Administration (FDA) has approved testosterone enanthate (Xyosted, Antares Pharma) subcutaneous injection for testosterone replacement therapy in men diagnosed with conditions ...
Xyosted carries a Boxed Warning regarding blood pressure increases that may potentially increase the risk for major adverse cardiovascular events. The Food and Drug Administration (FDA) has approved ...
Shares of Antares Pharma (NASDAQ: ATRS) were up 16.7% at 12:12 p.m. EDT on Tuesday after the company gained Food and Drug Administration (FDA) approval for its testosterone treatment Xyosted. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results